Shrivastava Sanjay's Insider Trades & SAST Disclosures
Shrivastava Sanjay's most recent trade in enVVeno Medical Corporation was a trade of 5,400 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on Dec. 24, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Shrivastava Sanjay.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 24 Dec 2024 | 5,400 | 9,288 (0%) | 0% | 2.9 | 15,660 | Common Stock |
| enVVeno Medical Corporation | Shrivastava Sanjay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 19,752 | 19,752 | - | - | Stock Options | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 13,856 | 13,856 | - | - | Stock Options | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 8,403 | 8,403 | - | - | Stock Options | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 30 Jun 2022 | 1,000 | 3,888 (0%) | 0% | 3.9 | 3,850 | Common Stock |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,211 | 7,211 | - | - | Stock Options | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 388 | 0 | - | - | Restricted Stock Units | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 388 | 2,888 (0%) | 0% | - | Common Stock | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 5,673 | 5,673 | - | - | Stock Option | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2020 | 100,000 | 100,000 | - | - | Stock Option | |
| enVVeno Medical Corporation | Sanjay Shrivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2020 | 62,500 | 97,500 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges